<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?properties open_access?><?properties manuscript?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-journal-id">9005353</journal-id><journal-id journal-id-type="pubmed-jr-id">1149</journal-id><journal-id journal-id-type="nlm-ta">Cytokine</journal-id><journal-id journal-id-type="iso-abbrev">Cytokine</journal-id><journal-title-group><journal-title>Cytokine</journal-title></journal-title-group><issn pub-type="ppub">1043-4666</issn><issn pub-type="epub">1096-0023</issn></journal-meta><article-meta><article-id pub-id-type="pmid">34284276</article-id><article-id pub-id-type="pmc">11325844</article-id><article-id pub-id-type="doi">10.1016/j.cyto.2021.155639</article-id><article-id pub-id-type="manuscript">HHSPA2011667</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Cytokine profiles in children with acute intussusception in South Africa</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Bessey</surname><given-names>Theresa K.</given-names></name><xref rid="A1" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name><surname>Parashar</surname><given-names>Umesh D.</given-names></name><xref rid="A1" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name><surname>Tate</surname><given-names>Jacqueline E.</given-names></name><xref rid="A1" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><collab>The South African Intussusception Surveillance Group</collab><xref rid="FN4" ref-type="fn">1</xref></contrib><contrib contrib-type="author"><name><surname>Madhi</surname><given-names>Shabir A.</given-names></name><xref rid="A2" ref-type="aff">b</xref></contrib><contrib contrib-type="author"><name><surname>Jiang</surname><given-names>Baoming</given-names></name><xref rid="A1" ref-type="aff">a</xref><xref rid="CR1" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><name><surname>Groome</surname><given-names>Michelle J.</given-names></name><xref rid="A2" ref-type="aff">b</xref></contrib></contrib-group><aff id="A1"><label>a</label>Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention (CDC), Atlanta, GA, USA</aff><aff id="A2"><label>b</label>South African Medical Research Council/Wits Vaccines and Infectious Diseases Analytics Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa</aff><author-notes><corresp id="CR1"><label>*</label>Corresponding author at: Viral Gastroenteritis Branch, National Center for Immunization and Respiratory Diseases, MS H18-7, 1600 Clifton Road NE, Atlanta, GA 30329, USA. <email>bxj4@cdc.gov</email> (B. Jiang).</corresp></author-notes><pub-date pub-type="nihms-submitted"><day>31</day><month>7</month><year>2024</year></pub-date><pub-date pub-type="ppub"><month>10</month><year>2021</year></pub-date><pub-date pub-type="epub"><day>17</day><month>7</month><year>2021</year></pub-date><pub-date pub-type="pmc-release"><day>15</day><month>8</month><year>2024</year></pub-date><volume>146</volume><fpage>155639</fpage><lpage>155639</lpage><permissions><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbyncndlicense">https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref><license-p>This is an open access article under the CC BY-NC-ND license (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">http://creativecommons.org/licenses/by-nc-nd/4.0/</ext-link>).</license-p></license></permissions><abstract id="ABS1"><p id="P1">Serum specimens of children hospitalized with acute intussusception (IS; n = 407) were analyzed for various pro- and anti-inflammatory cytokines to identify host markers specifically for IS compared to other surgical conditions (n = 235) or acute gastroenteritis (AGE; n = 68) in a cross-sectional study design. We showed that children with IS had elevated levels of pro-inflammatory cytokines IFN-&#x003b3;, TNF-&#x003b1;, MIP-1&#x003b2;, IL-1&#x003b2;, IL-2, IL-6, IL-7, IL-8, and IL-17 as well as anti-inflammatory cytokines IL-1RA, IL-4, IL-5, and IL-13 compared to those admitted with surgical conditions or AGE symptoms, indicating these cytokines as markers for IS. In addition, we showed an increase in C-reactive protein (CRP) levels in children with IS. This study is the first to show a broad cytokine profile and identify cytokine markers in children with IS.</p></abstract><kwd-group><kwd>Intussusception</kwd><kwd>Surveillance</kwd><kwd>C-reactive protein</kwd><kwd>Pro-inflammatory cytokines</kwd><kwd>Rotavirus vaccination</kwd><kwd>Acute Gastroenteritis</kwd><kwd>IFN-&#x003b3;</kwd></kwd-group></article-meta></front><body><sec id="S1"><label>1.</label><title>Introduction</title><p id="P2">Intussusception (IS), the invagination of one bowel segment into the adjacent segment, is one of the leading causes of childhood bowel obstruction. The incidence is greatest in infants and usually peaks between 4 and 10 months of age [<xref rid="R1" ref-type="bibr">1</xref>,<xref rid="R2" ref-type="bibr">2</xref>]. If untreated, blood circulation of the affected part can be compromised, resulting in bowel obstruction, intestinal ischemia, perforation or fatality. IS rates vary by population due to differences in ethnicity, environmental factors, and access to health care among others [<xref rid="R1" ref-type="bibr">1</xref>,<xref rid="R3" ref-type="bibr">3</xref>,<xref rid="R4" ref-type="bibr">4</xref>]. The etiology of IS remains unclear but various pathogens, especially adenovirus, have been reported to be associated with the onset of acute IS in children [<xref rid="R5" ref-type="bibr">5</xref>]. Viral and bacterial infectious diseases can lead to the increase of Interleukin (IL)- 6 and Tumor-Necrosis-Factor (TNF)-&#x003b1; in serum of patients [<xref rid="R6" ref-type="bibr">6</xref>,<xref rid="R7" ref-type="bibr">7</xref>]. Both of these cytokines are known to affect gastrointestinal motility which could affect or promote IS development [<xref rid="R8" ref-type="bibr">8</xref>]. However, no broad cytokine profiling of patients with natural intussusception has been reported to date.</p><p id="P3">Following the licensing of the oral rotavirus (RV) vaccine RotaShield in 1999, an association between IS and this vaccine was found leading ultimately to its withdrawal from the market in the United States [<xref rid="R9" ref-type="bibr">9</xref>,<xref rid="R10" ref-type="bibr">10</xref>]. New generation oral, live-attenuated RV vaccines, Rotarix and RotaTeq, were evaluated for an association between vaccination and IS in large clinical trials [<xref rid="R11" ref-type="bibr">11</xref>,<xref rid="R12" ref-type="bibr">12</xref>]. No association was found, leading to the licensure of those vaccines for the global market in 2006 [<xref rid="R9" ref-type="bibr">9</xref>,<xref rid="R13" ref-type="bibr">13</xref>]. However, post-licensure surveillance in several high- and middle-income countries has shown a low risk of intussusception associated with both RotaTeq and Rotarix [<xref rid="R14" ref-type="bibr">14</xref>-<xref rid="R16" ref-type="bibr">16</xref>]. Interestingly, no risk of intussusception was found with Rotarix vaccination in a large post-licensure evaluation of this vaccine in seven low-income African countries and with Rotavac, an Indian-made rotavirus vaccine licensed in 2014, in a post-licensure study in India [<xref rid="R3" ref-type="bibr">3</xref>,<xref rid="R17" ref-type="bibr">17</xref>]. These data suggest that intussusception risk associated with rotavirus vaccination is likely related to intestinal replication and inflammation caused by the live oral vaccine strain. Other factors such as interference with other co-infecting pathogens, malnutrition, or level of maternal antibody that might affect vaccine virus replication in the gut can also result in IS development [<xref rid="R18" ref-type="bibr">18</xref>].</p><p id="P4">The current study presents data generated from post-licensure monitoring of IS in South Africa after the introduction of Rotarix vaccine into the national immunization program in 2009 [<xref rid="R19" ref-type="bibr">19</xref>]. The primary study did not find an association of intussusception with rotavirus vaccination in South African infants [<xref rid="R19" ref-type="bibr">19</xref>]. Cytokine profiles in children hospitalized with acute IS were analyzed to identify markers for natural occurring IS compared to other surgical conditions or acute gastroenteritis (AGE).</p></sec><sec id="S2"><label>2.</label><title>Materials and Methods</title><sec id="S3"><label>2.1.</label><title>Patients and sample collection</title><p id="P5">Patients were enrolled from 8 hospital complexes in South Africa during an active intussusception surveillance program from 2013 to 2018 [<xref rid="R19" ref-type="bibr">19</xref>]. The enrollment hospitals included Chris Hani Baragwanath Academic Hospital (CHBAH) and Charlotte Maxeke Johannesburg Academic Hospital in Johannesburg; Red Cross War Memorial Children&#x02019;s and Tygerberg Hospitals in Cape Town; Steve Biko Academic/Kalafong Hospital in Pretoria; East London Hospital Complex in East London; Universitas Hospital in Bloemfontein and Inkosi Albert Luthuli Hospital in Durban. Cases were patients &#x0003c;3 years of age hospitalized with evidence of intussusception according to Level 1 Brighton criteria [<xref rid="R20" ref-type="bibr">20</xref>]. Control patients hospitalized with non-intussusception surgical conditions were enrolled from all hospitals and control patients hospitalized with acute gastroenteritis symptoms were only enrolled from CHBAH hospital. Control patients were matched with case patients on age (born&#x000b1;90 days), date of hospitalization (within 90 days of the case) and hospital. Vaccination status and basic demographics were collected upon enrollment. Informed consent was obtained from all caregivers before participating in this study.</p><p id="P6">Approvals were obtained from the ethics committees of the University of the Witwatersrand (M120934), University of KwaZulu-Natal (BE263/14), University of Cape Town (587/2013), University of Stellenbosch (N12/12/085), University of the Free State (ETOVS 84/2014), University of Pretoria (345/2013) and Walter Sisulu University (051/012).</p><p id="P7">Blood was collected from patients when first presented to the hospital site and serum was prepared by centrifugation, subsequently aliquoted and stored at &#x02212;80 &#x000b0;C.</p></sec><sec id="S4"><label>2.2.</label><title>C-reactive protein (CRP) assay</title><p id="P8">Serum CRP levels were measured using the Quantikine ELISA Human C-reactive Protein Immunoassay (R&#x00026;D Systems, Minneapolis, MN USA) according to manufacturer&#x02019;s instructions. For initial screening, samples were diluted 200-fold and tested in duplicate. Samples with an optical density (OD) above the OD of the standard curve were retested at a 400- and 800-fold dilution each in duplicate for accurate calculation of CRP concentration. The normal serum CRP concentration in children is below 5 mg/L.</p></sec><sec id="S5"><label>2.3.</label><title>Multi-plex cytokine assay</title><p id="P9">Serum was analyzed by using the Bio-plex Pro Human Cytokine 27-plex Assay (BioRad, Hercules, CA USA) for IL-1&#x003b2;, IL-1RA, IL-2, IL-4, IL-5, IL-6, IL-7, IL-8, IL-9, IL-10, IL-12(p70), IL-13, IL-15, IL-17, Eotaxin, basic FGF, G-CSF, GM-CSF, IFN-&#x003b3;, IP-10, MCP-1, MIP-1&#x003b1;, MIP-1&#x003b2;, PDGF-BB, RANTES, TNF-&#x003b1;, and VEGF. Serum was diluted 4-fold and assay was performed according to manufacturer&#x02019;s instructions. Samples were measured using MAGPIX (Luminex, Austin, TX USA) reader. Data were analyzed by using xTAG Data Analysis Software (Luminex, Austin, TX USA) and BioPlex Manager Software (BioRad, Hercules, CA, USA).</p></sec><sec id="S6"><label>2.4.</label><title>Statistical analysis</title><p id="P10">Statistical analysis between Case, Surgical and AGE Control groups was done using the one-way ANOVA with Turkey&#x02019;s multiple comparison test and a 95% confidence interval or unpaired, two-tailed <italic toggle="yes">t</italic> test for 2 variables. Statistical significance was accepted when p &#x0003c; 0.05 with *: p &#x0003c; 0.05; ** p &#x0003c; 0.01; ***: p &#x0003c; 0.001; ns: p &#x02265; 0.05 and performed with GraphPad Prism for Windows (Version 5.02, GraphPad Software, San Diego, CA USA).</p></sec></sec><sec id="S7"><label>3.</label><title>Results</title><p id="P11">The active intussusception (IS) surveillance program in South Africa recruited IS patients and controls from September 2013 to January 2018. Serum specimens were obtained from 407 IS case patients, 235 surgical control patients, and 68 AGE control patients and used for cytokine testing (<xref rid="T1" ref-type="table">Table 1</xref>). Of the 407 children admitted with IS, pneumatic reduction was used for around 68% and surgical reduction was used for around 30% of cases for the initial treatment (<xref rid="SD1" ref-type="supplementary-material">Supplementary Table 1</xref>). Gender distribution of IS cases and AGE controls were comparable; however, we observed a significantly higher number of male patients in the surgical control group (73.2%) compared to IS cases (55%; p &#x0003c; 0.001) and AGE control group (58.8%; p &#x0003c; 0.001). The majority of children in all groups were vaccinated against RV with at least one dose (88% in IS case patients; 90.2% in surgical control patients; 94.1% in AGE control patients; p = 0.37). In the surgical control group, children were admitted with a variety of elective surgery conditions (<xref rid="SD1" ref-type="supplementary-material">Supplementary Table 2</xref>). The largest proportion of children were admitted with inguinal hernia (37%) and anorectal malformation (18.7%).</p><p id="P12">Serum CRP concentrations, a liver enzyme upregulated in serum during various inflammatory conditions, were significantly higher in IS case patients (mean 25.3 mg/ml) compared to surgical control patients (mean 9.1 mg/ml) and AGE control patients (mean 11.8 mg/ml) (<xref rid="F1" ref-type="fig">Fig. 1</xref>, **** p &#x0003c; 0.0001). CRP levels in AGE control patients were also elevated compared to surgical controls however the difference was not statistically significant (p = 0.43).</p><p id="P13">Serum analysis showed a significant increase in a variety of pro-inflammatory and anti-inflammatory cytokines in IS cases compared to surgical control and AGE control patients (<xref rid="T2" ref-type="table">Table 2</xref>). The largest increase in pro-inflammatory cytokines was seen for IL-1&#x003b2;, IL-6, and IL-8 compared to surgical control and AGE control patients. In addition, pro-inflammatory cytokines IFN-&#x003b3;, TNF-&#x003b1;, TNF-1&#x003b2;, PDGF-BB, IL-2, IL-7, and IL-17 were significantly upregulated in IS cases as well. No difference could be detected between cytokine levels in surgical control and AGE control patients. Interestingly, we observed significantly elevated IL-6, and CRP expression as well as a trend for elevated TNF-&#x003b1; expression in only IS patients that underwent surgical reduction for IS compared to pneumatic reduction (<xref rid="SD3" ref-type="supplementary-material">Supplementary Fig. 1</xref>). Anti-inflammatory cytokines IL-1RA, IL-4, IL-5, IL-13, and basic FGF were significantly elevated in IS cases compared to surgical control patients. Also, we observed elevated level of IL-1RA in AGE control patients, but the increase was not statistically significant compared to surgical control patients.</p><p id="P14">Besides cytokines exclusively upregulated in IS case patients, we observed elevated levels of pro-inflammatory cytokines IL-12p70, IL-15, GM-CSF, MCP-1, and MIP-&#x003b1; in serum of IS case and surgical control patients compared to AGE control patients (<xref rid="T3" ref-type="table">Table 3</xref>). Mean cytokine levels of IL-12p70, IL-15, and GM-CSF in IS cases were significantly elevated compared to levels in AGE control patients, but only IL-15 is significantly upregulated comparing surgical to AGE controls. However, the mean cytokine levels in surgical control patients were elevated compared to AGE control patients though not statistically significant. Additionally, we measured an elevated expression of the anti-inflammatory cytokine G-CSF in IS cases and surgical control patients compared to AGE control patients although not statistically significant. No specific cytokine upregulation for the different subgroups of surgical control patients could be detected (data not shown).</p><p id="P15">In addition, we detected two cytokines, the pro-inflammatory cytokine eotaxin and the anti-inflammatory cytokine IL-10, significantly upregulated in IS cases and AGE control patients compared to surgical control patients (<xref rid="T4" ref-type="table">Table 4</xref>). The pro-inflammatory cytokine IP-10 was the only cytokine significantly upregulated exclusively in AGE control patients compared to IS cases and surgical controls (<xref rid="T4" ref-type="table">Table 4</xref>) (p &#x0003c; 0.001). We could not detect any differences in cytokine levels when comparing viral AGE with bacterial AGE cases in this control group (data not shown).</p><p id="P16">No changes in sera of IS case, surgical control and AGE control patients were observed for the pro-inflammatory cytokines IL-9, RANTES, and VEGF (<xref rid="SD1" ref-type="supplementary-material">Supplementary Table 3</xref>).</p></sec><sec id="S8"><label>4.</label><title>Discussion &#x00026; Conclusion</title><p id="P17">During this study, we identified various pro- and anti-inflammatory cytokines in sera of children with acute IS compared to surgical control and AGE control patients. Specifically, we showed the increase of pro-inflammatory IFN-&#x003b3;, TNF-&#x003b1;, MIP-1&#x003b2;, IL-1&#x003b2;, IL-2, IL-6, IL-7, IL-8, IL-17, and PDGF-BB as well as anti-inflammatory IL-1RA, IL-4, IL-5, IL-13, and basic FGF in children with acute IS compared to surgical control patients. In addition, we showed a significant increase of CRP in sera of children with IS compared to the two control groups. An increase in IFN-&#x003b3;, IL-6, TNF-&#x003b1; and CRP has been previously associated with IS severity in children and experimental animal models [<xref rid="R8" ref-type="bibr">8</xref>,<xref rid="R21" ref-type="bibr">21</xref>-<xref rid="R23" ref-type="bibr">23</xref>].</p><p id="P18">IS can be treated by pneumatic reduction or surgical reduction, both with potential resection of the affected bowel if reduction is not successful. A previous study compared different IS reduction methods and found that children with surgical IS reduction showed an increase of IL-6 and TNF-&#x003b1;, and a significant increase of CRP levels compared to children with non-operative IS conditions (pneumatic reduction), positively correlating CRP levels and disease severity [<xref rid="R21" ref-type="bibr">21</xref>]. In our study, we also detected an increase of IL-6, TNF-&#x003b1;, and CRP in IS cases that needed surgical reduction compared to pneumatic reduction (<xref rid="SD3" ref-type="supplementary-material">Supplementary Fig. 1</xref>). However, the difference between pneumatic and surgical reduction was not statistically significant for TNF-&#x003b1; due to reduced sample size.</p><p id="P19">Previous studies identified a lack of association of upregulated pro-inflammatory cytokines MIP-1&#x003b2;, PDGF-BB, IL-1&#x003b2;, IL-2, IL-7, and IL-8, and anti-inflammatory cytokines IL-1RA, IL-4, IL-5, IL-13, and basic FGF with IS. However, these cytokines have been associated with various inflammatory conditions, infection, autoimmune diseases, and chronic inflammation in patients [<xref rid="R24" ref-type="bibr">24</xref>-<xref rid="R27" ref-type="bibr">27</xref>]. By contrast, the presented study is the first of its kind to show a broad cytokine upregulation in children with acute IS. Interestingly, IL-5 and eotaxin were linked to eosinophilic enteritis, a condition that can cause intussusception and is characterized by increased eosinophil recruitment in the intestine [<xref rid="R28" ref-type="bibr">28</xref>-<xref rid="R30" ref-type="bibr">30</xref>]. Here, we also showed the upregulation of IL-5 and Eotaxin in IS patients. A direct link of these two cytokines and the manifestation of natural occurring IS needs further investigation.</p><p id="P20">Vaccinations are known to alter cytokine profiles upon administration. Here we showed that only the expression of IL-7 (p = 0.0352) and IL-12p70 (p = 0.0201) was significantly elevated in non-vaccinated children compared to vaccinated children with acute IS (<xref rid="SD2" ref-type="supplementary-material">Supplementary Fig. 2</xref>). Due to the low number of non-vaccinated children in this study setting, no significant increase or decrease in cytokine expression could be found for any of the other cytokines analyzed. In addition, rotavirus vaccination did not seem to alter the cytokine profile in children in the present study. Only 18 children were admitted with acute IS within 10 days of receiving any rotavirus vaccination dose. When analyzing the cytokine profiles of children admitted &#x0003c;10 days compared to children admitted &#x02265;10 days after receiving a rotavirus vaccine, only IL-1RA was significantly elevated in children &#x0003c;10 days (data not shown). Rotavirus infection and vaccination is known to induce Th1 cytokines like IFN-&#x003b3;, IL-2, and IL12 as well as Th2 cytokines like IL4, IL-6, and IL-10 [<xref rid="R31" ref-type="bibr">31</xref>,<xref rid="R32" ref-type="bibr">32</xref>]. However, here we showed that IL-2, IL-6, IL-4, and IFN-&#x003b3; were associated with IS rather than rotavirus infection or vaccination. An effect of other vaccinations on the cytokine profile could not fully be excluded since no records of vaccinations beside rotavirus were noted in this study.</p><p id="P21">Increase in the pro-inflammatory cytokines/chemokines IL-12, IL-15, GM-CSF, MCP-1, and MIP-1&#x003b1; were seen in IS cases as well as in surgical control patients. While those cytokines have been associated with various inflammatory diseases like rheumatoid arthritis, inflammatory bowel disease, celiac disease, and autoimmune diseases [<xref rid="R33" ref-type="bibr">33</xref>-<xref rid="R36" ref-type="bibr">36</xref>], the relation of these cytokines has not been previously investigated with IS. GM-CSF and G-CSF are known to be induced by IL-1&#x003b2;, TNF-&#x003b1;, or IL-12 [<xref rid="R37" ref-type="bibr">37</xref>,<xref rid="R38" ref-type="bibr">38</xref>]. We showed that these three cytokines were upregulated in IS patients which could explain the increased production of GM-CSF and G-CSF in IS patients. We could not detect cytokines exclusively upregulated in surgical control patients compared to the other groups as well as no specific cytokine upregulation for the different surgical conditions most likely due to the diversity of this group. The surgical control group in this study was presented as a heterogenous group and cytokine profiles and levels were dependent on the type of (inflammatory) condition as well as the time the children were admitted to the hospital. Rapid increase and decrease of cytokines in serum of children could have influenced the detection of cytokine levels in the presented study.</p><p id="P22">Of note, detection of cytokines in AGE control patients was limited in this study to an increase in eotaxin, IL-10, and IP-10 as well as an intermediate increase in CRP levels when compared to IS cases and surgical controls. During bacterial and viral infections, various cytokines are up or down regulated, depending on the nature of the pathogen. However, the cytokines detected here are known to have broad reactivity to various inflammatory and infectious conditions. No differences were seen when analyzing the cytokines in bacterial versus viral AGE (data not shown). For CRP, it has been shown that bacterial infection leads to a stronger increase in serum CRP than viral infections [<xref rid="R39" ref-type="bibr">39</xref>,<xref rid="R40" ref-type="bibr">40</xref>]. However, we were not able to draw this conclusion from this study. As seen for surgical control patients, in AGE control patients the nature of infection as well as severity and duration of hospitalization may play a crucial role in the detection of serum cytokines. In addition, the smaller sample size of the AGE control patients limited the statistical analysis for most cytokines.</p><p id="P23">The present study has limitations. Incidence rate of RV vaccine associated IS is highest up to 21 days after vaccination [<xref rid="R41" ref-type="bibr">41</xref>]. In this study, the average time of IS onset after vaccination was &#x0003e;100 days indicating no correlation of RV vaccination in the development of IS [<xref rid="R19" ref-type="bibr">19</xref>]. Only 30 cases were admitted with IS that occurred up to 21 days after RV vaccination and because of small sample size, those cases were not excluded in the analysis. Further studies are needed to examine specific biomarkers in response to IS from RV vaccination among children in middle- or high-income settings where RV vaccines are associated with rare but severe IS. Nevertheless, this study is the first to identify a wide range of cytokines upregulated exclusively in IS patients compared to control patients. Our data may help increase our understanding of host responses to IS and identify potential biomarkers to better manage and improve the outcome of this disease in children.</p></sec><sec sec-type="supplementary-material" id="SM1"><title>Supplementary Material</title><supplementary-material id="SD1" position="float" content-type="local-data"><label>Suppl Table 1</label><media xlink:href="NIHMS2011667-supplement-Suppl_Table_1.docx" id="d67e378" position="anchor"/></supplementary-material><supplementary-material id="SD2" position="float" content-type="local-data"><label>Suppl Fig 2</label><media xlink:href="NIHMS2011667-supplement-Suppl_Fig_2.pptx" id="d67e381" position="anchor"/></supplementary-material><supplementary-material id="SD3" position="float" content-type="local-data"><label>Suppl Fig 1</label><media xlink:href="NIHMS2011667-supplement-Suppl_Fig_1.pptx" id="d67e384" position="anchor"/></supplementary-material></sec></body><back><ack id="S9"><title>Financial Support</title><p id="P24">Support for this project was provided by the Bill &#x00026; Melinda Gates Foundation (BMGF) (grant number OPP1066762).</p><sec id="S10"><title>Funding</title><p id="P25">The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention. The funding source had no role in the writing of the manuscript or the decision to submit it for publication.</p></sec></ack><fn-group><fn id="FN4"><label>1</label><p id="P26">The South African Intussusception Surveillance Group: Marion Arnold<sup>c,d</sup>, Milind Chitnis<sup>e</sup>, Sharon Cox<sup>c</sup>, Corn&#x000e9; de Vos<sup>d</sup>, Mari Kirsten<sup>f</sup>, Susanna M. le Grange<sup>8</sup>, Jerome Loveland<sup>h</sup>, Sello Machaea<sup>e</sup>, Ashwini Maharaj<sup>l</sup>, Aletha Withers<sup>h</sup>. <sup>c</sup>Red Cross War Memorial Children&#x02019;s Hospital, University of Cape Town, Cape Town, South Africa; <sup>d</sup>Tygerberg Hospital, University of Stellenbosch, Cape Town, South Africa; <sup>e</sup>East London Hospital Complex, Walter Sisulu University, East London, South Africa; <sup>f</sup>Steve Biko Academic Hospital/Kalafong Hospital, University of Pretoria, South Africa; <sup>g</sup>Universitas Hospital, University of the Free State, Bloemfontein, South Africa; <sup>h</sup>Department of Paediatric Surgery, University of the Witwatersrand, Johannesburg, South Africa; <sup>I</sup>Inkosi Albert Luthuli Hospital, University of Kwa-Zulu Natal, Durban, South Africa.</p></fn><fn id="FN1"><p id="P27">CRediT authorship contribution statement</p><p id="P28"><bold>Theresa K. Bessey:</bold> Investigation, Writing - original draft, Methodology, Validation, Formal analysis, Visualization. <bold>Umesh D. Parashar:</bold> Supervision, Writing - review &#x00026; editing, Conceptualization, Resources, Funding acquisition. <bold>Jacqueline E. Tate:</bold> Writing - review &#x00026; editing, Formal analysis. <bold>Shabir A. Madhi:</bold> Conceptualization, Methodology, Data curation. <bold>Baoming Jiang:</bold> Conceptualization, Supervision, Writing - review &#x00026; editing, Methodology, Resources. <bold>Michelle J. Groome:</bold> Conceptualization, Methodology, Data curation, Writing - review &#x00026; editing, Supervision.:.</p></fn><fn id="FN2"><p id="P29">Declaration of Competing Interest</p><p id="P30">The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</p></fn><fn id="FN3"><p id="P31">Appendix A. Supplementary material</p><p id="P32">Supplementary data to this article can be found online at <ext-link xlink:href="10.1016/j.cyto.2021.155639" ext-link-type="doi">https://doi.org/10.1016/j.cyto.2021.155639</ext-link>.</p></fn></fn-group><glossary><title>Abbreviations:</title><def-list><def-item><term>IS</term><def><p id="P33">Intussusception</p></def></def-item><def-item><term>AGE</term><def><p id="P34">Acute gastroenteritis</p></def></def-item><def-item><term>RV</term><def><p id="P35">Rotavirus</p></def></def-item></def-list></glossary><ref-list><title>References</title><ref id="R1"><label>[1]</label><mixed-citation publication-type="journal"><name><surname>Jiang</surname><given-names>J</given-names></name>, <name><surname>Jiang</surname><given-names>B</given-names></name>, <name><surname>Parashar</surname><given-names>U</given-names></name>, <name><surname>Nguyen</surname><given-names>T</given-names></name>, <name><surname>Bines</surname><given-names>J</given-names></name>, <name><surname>Patel</surname><given-names>MM</given-names></name>, <article-title>Childhood intussusception: a literature review</article-title>, <source>PloS One</source>
<volume>8</volume> (<issue>7</issue>) (<year>2013</year>), <fpage>e68482</fpage>.<pub-id pub-id-type="pmid">23894308</pub-id>
</mixed-citation></ref><ref id="R2"><label>[2]</label><mixed-citation publication-type="book"><collab>O. World Health</collab>, <source>Acute intussusception in infants and children: incidence, clinical representation and management: a global perspective</source>, <publisher-name>World Health Organization</publisher-name>, <publisher-loc>Geneva</publisher-loc>, <year>2002</year>.</mixed-citation></ref><ref id="R3"><label>[3]</label><mixed-citation publication-type="journal"><name><surname>Tate</surname><given-names>JE</given-names></name>, <name><surname>Mwenda</surname><given-names>JM</given-names></name>, <name><surname>Armah</surname><given-names>G</given-names></name>, <name><surname>Jani</surname><given-names>B</given-names></name>, <name><surname>Omore</surname><given-names>R</given-names></name>, <name><surname>Ademe</surname><given-names>A</given-names></name>, <name><surname>Mujuru</surname><given-names>H</given-names></name>, <name><surname>Mpabalwani</surname><given-names>E</given-names></name>, <name><surname>Ngwira</surname><given-names>B</given-names></name>, <name><surname>Cortese</surname><given-names>MM</given-names></name>, <name><surname>Mihigo</surname><given-names>R</given-names></name>, <name><surname>Glover-Addy</surname><given-names>H</given-names></name>, <name><surname>Mbaga</surname><given-names>M</given-names></name>, <name><surname>Osawa</surname><given-names>F</given-names></name>, <name><surname>Tadesse</surname><given-names>A</given-names></name>, <name><surname>Mbuwayesango</surname><given-names>B</given-names></name>, <name><surname>Simwaka</surname><given-names>J</given-names></name>, <name><surname>Cunliffe</surname><given-names>N</given-names></name>, <name><surname>Lopman</surname><given-names>BA</given-names></name>, <name><surname>Weldegebriel</surname><given-names>G</given-names></name>, <name><surname>Ansong</surname><given-names>D</given-names></name>, <name><surname>Msuya</surname><given-names>D</given-names></name>, <name><surname>Ogwel</surname><given-names>B</given-names></name>, <name><surname>Karengera</surname><given-names>T</given-names></name>, <name><surname>Manangazira</surname><given-names>P</given-names></name>, <name><surname>Bvulani</surname><given-names>B</given-names></name>, <name><surname>Yen</surname><given-names>C</given-names></name>, <name><surname>Zawaira</surname><given-names>FR</given-names></name>, <name><surname>Narh</surname><given-names>CT</given-names></name>, <name><surname>Mboma</surname><given-names>L</given-names></name>, <name><surname>Saula</surname><given-names>P</given-names></name>, <name><surname>Teshager</surname><given-names>F</given-names></name>, <name><surname>Getachew</surname><given-names>H</given-names></name>, <name><surname>Moeti</surname><given-names>RM</given-names></name>, <name><surname>Eweronu-Laryea</surname><given-names>C</given-names></name>, <name><surname>Parashar</surname><given-names>UD</given-names></name>, <collab>N. African Intussusception Surveillance</collab>, <article-title>Evaluation of Intussusception after Monovalent Rotavirus Vaccination in Africa</article-title>, <source>New Engl. J. Med</source>
<volume>378</volume>(<issue>16</issue>) (<year>2018</year>) <fpage>1521</fpage>&#x02013;<lpage>1528</lpage>.<pub-id pub-id-type="pmid">29669224</pub-id>
</mixed-citation></ref><ref id="R4"><label>[4]</label><mixed-citation publication-type="journal"><name><surname>Chen</surname><given-names>SC</given-names></name>, <name><surname>Wang</surname><given-names>JD</given-names></name>, <name><surname>Hsu</surname><given-names>HY</given-names></name>, <name><surname>Leong</surname><given-names>MM</given-names></name>, <name><surname>Tok</surname><given-names>TS</given-names></name>, <name><surname>Chin</surname><given-names>YY</given-names></name>, <article-title>Epidemiology of childhood intussusception and determinants of recurrence and operation: analysis of national health insurance data between 1998 and 2007 in Taiwan</article-title>, <source>Pediatr. Neonatol</source>
<volume>51</volume> (<issue>5</issue>) (<year>2010</year>) <fpage>285</fpage>&#x02013;<lpage>291</lpage>.<pub-id pub-id-type="pmid">20951359</pub-id>
</mixed-citation></ref><ref id="R5"><label>[5]</label><mixed-citation publication-type="journal"><name><surname>Burnett</surname><given-names>E</given-names></name>, <name><surname>Parashar</surname><given-names>UD</given-names></name>, <name><surname>Tate</surname><given-names>JE</given-names></name>, <article-title>Associations of Intussusception With Adenovirus, Rotavirus, and Other Pathogens: A Review of the Literature</article-title>, <source>Pediatr. Infect. Dis. J</source>
<volume>39</volume> (<issue>12</issue>) (<year>2020</year>) <fpage>1127</fpage>&#x02013;<lpage>1130</lpage>.<pub-id pub-id-type="pmid">33060518</pub-id>
</mixed-citation></ref><ref id="R6"><label>[6]</label><mixed-citation publication-type="journal"><name><surname>Joshi</surname><given-names>L</given-names></name>, <name><surname>Ponnana</surname><given-names>M</given-names></name>, <name><surname>Sivangala</surname><given-names>R</given-names></name>, <name><surname>Chelluri</surname><given-names>LK</given-names></name>, <name><surname>Nallari</surname><given-names>P</given-names></name>, <name><surname>Penmetsa</surname><given-names>S</given-names></name>, <name><surname>Valluri</surname><given-names>V</given-names></name>, <name><surname>Gaddam</surname><given-names>S</given-names></name>, <article-title>Evaluation of TNF-alpha IL-10 and IL-6 Cytokine Production and Their Correlation with Genotype Variants amongst Tuberculosis Patients and Their Household Contacts</article-title>, <source>PloS One</source>
<volume>10</volume> (<issue>9</issue>) (<year>2015</year>) <fpage>e0137727</fpage>.<pub-id pub-id-type="pmid">26359865</pub-id>
</mixed-citation></ref><ref id="R7"><label>[7]</label><mixed-citation publication-type="journal"><name><surname>Velazquez-Salinas</surname><given-names>L</given-names></name>, <name><surname>Verdugo-Rodriguez</surname><given-names>A</given-names></name>, <name><surname>Rodriguez</surname><given-names>LL</given-names></name>, <name><surname>Borca</surname><given-names>MV</given-names></name>, <article-title>The Role of Interleukin 6 During Viral Infections</article-title>, <source>Front. Microbiol</source>
<volume>10</volume> (<year>2019</year>) <fpage>1057</fpage>.<pub-id pub-id-type="pmid">31134045</pub-id>
</mixed-citation></ref><ref id="R8"><label>[8]</label><mixed-citation publication-type="journal"><name><surname>Sonmez</surname><given-names>K</given-names></name>, <name><surname>Karabulut</surname><given-names>R</given-names></name>, <name><surname>Turkyilmaz</surname><given-names>Z</given-names></name>, <name><surname>Demirogullari</surname><given-names>B</given-names></name>, <name><surname>Ozen</surname><given-names>IO</given-names></name>, <name><surname>Gulen</surname><given-names>S</given-names></name>, <name><surname>Basaklar</surname><given-names>AC</given-names></name>, <name><surname>Kale</surname><given-names>N</given-names></name>, <article-title>Association of tumor necrosis factor, interleukin-6 and cyclooxygenase pathway with lipopolysaccharide-induced intussusception</article-title>, <source>Eur. J. Pediatr. Surg</source>
<volume>18</volume> (<issue>2</issue>) (<year>2008</year>) <fpage>103</fpage>&#x02013;<lpage>106</lpage>.<pub-id pub-id-type="pmid">18437654</pub-id>
</mixed-citation></ref><ref id="R9"><label>[9]</label><mixed-citation publication-type="journal"><name><surname>Patel</surname><given-names>MM</given-names></name>, <name><surname>Parashar</surname><given-names>UD</given-names></name>, <article-title>Assessing the effectiveness and public health impact of rotavirus vaccines after introduction in immunization programs</article-title>, <source>J. Infectious Dis</source>
<volume>200</volume> (<issue>Suppl 1</issue>) (<year>2009</year>) <fpage>S291</fpage>&#x02013;<lpage>S299</lpage>.<pub-id pub-id-type="pmid">19817612</pub-id>
</mixed-citation></ref><ref id="R10"><label>[10]</label><mixed-citation publication-type="journal"><name><surname>Murphy</surname><given-names>TV</given-names></name>, <name><surname>Gargiullo</surname><given-names>PM</given-names></name>, <name><surname>Massoudi</surname><given-names>MS</given-names></name>, <name><surname>Nelson</surname><given-names>DB</given-names></name>, <name><surname>Jumaan</surname><given-names>AO</given-names></name>, <name><surname>Okoro</surname><given-names>CA</given-names></name>, <name><surname>Zanardi</surname><given-names>LR</given-names></name>, <name><surname>Setia</surname><given-names>S</given-names></name>, <name><surname>Fair</surname><given-names>E</given-names></name>, <name><surname>LeBaron</surname><given-names>CW</given-names></name>, <name><surname>Schwartz</surname><given-names>B</given-names></name>, <name><surname>Wharton</surname><given-names>M</given-names></name>, <name><surname>Livingood</surname><given-names>JR</given-names></name>, <article-title>Intussusception among Infants Given an Oral Rotavirus Vaccine</article-title>, <source>New Engl. J. Med</source>
<volume>344</volume> (<issue>8</issue>) (<year>2001</year>) <fpage>564</fpage>&#x02013;<lpage>572</lpage>.<pub-id pub-id-type="pmid">11207352</pub-id>
</mixed-citation></ref><ref id="R11"><label>[11]</label><mixed-citation publication-type="journal"><name><surname>Vesikari</surname><given-names>T</given-names></name>, <name><surname>Clark</surname><given-names>HF</given-names></name>, <name><surname>Offit</surname><given-names>PA</given-names></name>, <name><surname>Dallas</surname><given-names>MJ</given-names></name>, <name><surname>DiStefano</surname><given-names>DJ</given-names></name>, <name><surname>Goveia</surname><given-names>MG</given-names></name>, <name><surname>Ward</surname><given-names>RL</given-names></name>, <name><surname>Schodel</surname><given-names>F</given-names></name>, <name><surname>Karvonen</surname><given-names>A</given-names></name>, <name><surname>Drummond</surname><given-names>JE</given-names></name>, <name><surname>DiNubile</surname><given-names>MJ</given-names></name>, <name><surname>Heaton</surname><given-names>PM</given-names></name>, <article-title>Effects of the potency and composition of the multivalent human-bovine (WC3) reassortant rotavirus vaccine on efficacy, safety and immunogenicity in healthy infants</article-title>, <source>Vaccine</source>
<volume>24</volume> (<issue>22</issue>) (<year>2006</year>) <fpage>4821</fpage>&#x02013;<lpage>4829</lpage>.<pub-id pub-id-type="pmid">16621194</pub-id>
</mixed-citation></ref><ref id="R12"><label>[12]</label><mixed-citation publication-type="journal"><name><surname>Ruiz-Palacios</surname><given-names>GM</given-names></name>, <name><surname>Perez-Schael</surname><given-names>I</given-names></name>, <name><surname>Velazquez</surname><given-names>FR</given-names></name>, <name><surname>Abate</surname><given-names>H</given-names></name>, <name><surname>Breuer</surname><given-names>T</given-names></name>, <name><surname>Clemens</surname><given-names>SC</given-names></name>, <name><surname>Cheuvart</surname><given-names>B</given-names></name>, <name><surname>Espinoza</surname><given-names>F</given-names></name>, <name><surname>Gillard</surname><given-names>P</given-names></name>, <name><surname>Innis</surname><given-names>BL</given-names></name>, <name><surname>Cervantes</surname><given-names>Y</given-names></name>, <name><surname>Linhares</surname><given-names>AC</given-names></name>, <name><surname>Lopez</surname><given-names>P</given-names></name>, <name><surname>Macias-Parra</surname><given-names>M</given-names></name>, <name><surname>Ortega-Barria</surname><given-names>E</given-names></name>, <name><surname>Richardson</surname><given-names>V</given-names></name>, <name><surname>Rivera-Medina</surname><given-names>DM</given-names></name>, <name><surname>Rivera</surname><given-names>L</given-names></name>, <name><surname>Salinas</surname><given-names>B</given-names></name>, <name><surname>Pavia-Ruz</surname><given-names>N</given-names></name>, <name><surname>Salmeron</surname><given-names>J</given-names></name>, <name><surname>Ruttimann</surname><given-names>R</given-names></name>, <name><surname>Tinoco</surname><given-names>JC</given-names></name>, <name><surname>Rubio</surname><given-names>P</given-names></name>, <name><surname>Nunez</surname><given-names>E</given-names></name>, <name><surname>Guerrero</surname><given-names>ML</given-names></name>, <name><surname>Yarzabal</surname><given-names>JP</given-names></name>, <name><surname>Damaso</surname><given-names>S</given-names></name>, <name><surname>Tornieporth</surname><given-names>N</given-names></name>, <name><surname>Saez-Llorens</surname><given-names>X</given-names></name>, <name><surname>Vergara</surname><given-names>RF</given-names></name>, <name><surname>Vesikari</surname><given-names>T</given-names></name>, <name><surname>Bouckenooghe</surname><given-names>A</given-names></name>, <name><surname>Clemens</surname><given-names>R</given-names></name>, <name><surname>De Vos</surname><given-names>B</given-names></name>, <name><surname>O&#x02019;Ryan</surname><given-names>M</given-names></name>, <collab>G. Human Rotavirus Vaccine Study</collab>
<article-title>Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis</article-title>, <source>New Engl. J. Med</source>
<volume>354</volume> (<issue>1</issue>) (<year>2006</year>) <fpage>11</fpage>&#x02013;<lpage>22</lpage>.<pub-id pub-id-type="pmid">16394298</pub-id>
</mixed-citation></ref><ref id="R13"><label>[13]</label><mixed-citation publication-type="journal"><collab>O. World Health</collab>, <article-title>Rotavirus vaccines</article-title>, <source>Releve epidemiologique hebdomadaire</source>
<volume>82</volume> (<issue>32</issue>) (<year>2007</year>) <fpage>285</fpage>&#x02013;<lpage>295</lpage>.<pub-id pub-id-type="pmid">17691162</pub-id>
</mixed-citation></ref><ref id="R14"><label>[14]</label><mixed-citation publication-type="journal"><name><surname>Patel</surname><given-names>MM</given-names></name>, <name><surname>Lopez-Collada</surname><given-names>VR</given-names></name>, <name><surname>Bulhoes</surname><given-names>MM</given-names></name>, <name><surname>De Oliveira</surname><given-names>LH</given-names></name>, <name><surname>Bautista Marquez</surname><given-names>A</given-names></name>, <name><surname>Flannery</surname><given-names>B</given-names></name>, <name><surname>Esparza-Aguilar</surname><given-names>M</given-names></name>, <name><surname>Montenegro Renoiner</surname><given-names>EI</given-names></name>, <name><surname>Luna-Cruz</surname><given-names>ME</given-names></name>, <name><surname>Sato</surname><given-names>HK</given-names></name>, <name><surname>Hernandez-Hernandez Ldel</surname><given-names>C</given-names></name>, <name><surname>Toledo-Cortina</surname><given-names>G</given-names></name>, <name><surname>Ceron-Rodriguez</surname><given-names>M</given-names></name>, <name><surname>Osnaya-Romero</surname><given-names>N</given-names></name>, <name><surname>Martinez-Alcazar</surname><given-names>M</given-names></name>, <name><surname>Aguinaga-Villasenor</surname><given-names>RG</given-names></name>, <name><surname>Plascencia-Hernandez</surname><given-names>A</given-names></name>, <name><surname>Fojaco-Gonzalez</surname><given-names>F</given-names></name>, <name><surname>Hernandez-Peredo Rezk</surname><given-names>G</given-names></name>, <name><surname>Gutierrez-Ramirez</surname><given-names>SF</given-names></name>, <name><surname>Dorame-Castillo</surname><given-names>R</given-names></name>, <name><surname>Tinajero-Pizano</surname><given-names>R</given-names></name>, <name><surname>Mercado-Villegas</surname><given-names>B</given-names></name>, <name><surname>Barbosa</surname><given-names>MR</given-names></name>, <name><surname>Maluf</surname><given-names>EM</given-names></name>, <name><surname>Ferreira</surname><given-names>LB</given-names></name>, <name><surname>de Carvalho</surname><given-names>FM</given-names></name>, <name><surname>dos Santos</surname><given-names>AR</given-names></name>, <name><surname>Cesar</surname><given-names>ED</given-names></name>, <name><surname>de Oliveira</surname><given-names>ME</given-names></name>, <name><surname>Silva</surname><given-names>CL</given-names></name>, <name><surname>de Los Angeles Cortes</surname><given-names>M</given-names></name>, <name><surname>Ruiz Matus</surname><given-names>C</given-names></name>, <name><surname>Tate</surname><given-names>J</given-names></name>, <name><surname>Gargiullo</surname><given-names>P</given-names></name>, <name><surname>Parashar</surname><given-names>UD</given-names></name>, <article-title>Intussusception risk and health benefits of rotavirus vaccination in Mexico and Brazil</article-title>, <source>New Engl. J. Med</source>
<volume>364</volume>(<issue>24</issue>) (<year>2011</year>) <fpage>2283</fpage>&#x02013;<lpage>2292</lpage>.<pub-id pub-id-type="pmid">21675888</pub-id>
</mixed-citation></ref><ref id="R15"><label>[15]</label><mixed-citation publication-type="journal"><name><surname>Buttery</surname><given-names>JP</given-names></name>, <name><surname>Danchin</surname><given-names>MH</given-names></name>, <name><surname>Lee</surname><given-names>KJ</given-names></name>, <name><surname>Carlin</surname><given-names>JB</given-names></name>, <name><surname>McIntyre</surname><given-names>PB</given-names></name>, <name><surname>Elliott</surname><given-names>EJ</given-names></name>, <name><surname>Booy</surname><given-names>R</given-names></name>, <name><surname>Bines</surname><given-names>JE</given-names></name>, <name><surname>Group</surname><given-names>PAS</given-names></name>, <article-title>Intussusception following rotavirus vaccine administration: post-marketing surveillance in the National Immunization Program in Australia</article-title>, <source>Vaccine</source>
<volume>29</volume>(<issue>16</issue>) (<year>2011</year>) <fpage>3061</fpage>&#x02013;<lpage>3066</lpage>.<pub-id pub-id-type="pmid">21316503</pub-id>
</mixed-citation></ref><ref id="R16"><label>[16]</label><mixed-citation publication-type="journal"><name><surname>Haber</surname><given-names>P</given-names></name>, <name><surname>Patel</surname><given-names>M</given-names></name>, <name><surname>Pan</surname><given-names>Y</given-names></name>, <name><surname>Baggs</surname><given-names>J</given-names></name>, <name><surname>Haber</surname><given-names>M</given-names></name>, <name><surname>Museru</surname><given-names>O</given-names></name>, <name><surname>Yue</surname><given-names>X</given-names></name>, <name><surname>Lewis</surname><given-names>P</given-names></name>, <name><surname>Destefano</surname><given-names>F</given-names></name>, <name><surname>Parashar</surname><given-names>UD</given-names></name>, <article-title>Intussusception after rotavirus vaccines reported to US VAERS, 2006&#x02013;2012</article-title>, <source>Pediatrics</source>
<volume>131</volume> (<issue>6</issue>) (<year>2013</year>) <fpage>1042</fpage>&#x02013;<lpage>1049</lpage>.<pub-id pub-id-type="pmid">23669521</pub-id>
</mixed-citation></ref><ref id="R17"><label>[17]</label><mixed-citation publication-type="journal"><name><surname>Reddy</surname><given-names>SN</given-names></name>, <name><surname>Nair</surname><given-names>NP</given-names></name>, <name><surname>Tate</surname><given-names>JE</given-names></name>, <name><surname>Thiyagarajan</surname><given-names>V</given-names></name>, <name><surname>Giri</surname><given-names>S</given-names></name>, <name><surname>Praharaj</surname><given-names>I</given-names></name>, <name><surname>Mohan</surname><given-names>VR</given-names></name>, <name><surname>Babji</surname><given-names>S</given-names></name>, <name><surname>Gupte</surname><given-names>MD</given-names></name>, <name><surname>Arora</surname><given-names>R</given-names></name>, <name><surname>Bidari</surname><given-names>S</given-names></name>, <name><surname>Senthamizh</surname><given-names>S</given-names></name>, <name><surname>Mekala</surname><given-names>S</given-names></name>, <name><surname>Goru</surname><given-names>KB</given-names></name>, <name><surname>Reddy</surname><given-names>B</given-names></name>, <name><surname>Pamu</surname><given-names>P</given-names></name>, <name><surname>Gorthi</surname><given-names>RP</given-names></name>, <name><surname>Badur</surname><given-names>M</given-names></name>, <name><surname>Mohan</surname><given-names>V</given-names></name>, <name><surname>Sathpathy</surname><given-names>S</given-names></name>, <name><surname>Mohanty</surname><given-names>H</given-names></name>, <name><surname>Dash</surname><given-names>M</given-names></name>, <name><surname>Mohakud</surname><given-names>NK</given-names></name>, <name><surname>Ray</surname><given-names>RK</given-names></name>, <name><surname>Mohanty</surname><given-names>P</given-names></name>, <name><surname>Gathwala</surname><given-names>G</given-names></name>, <name><surname>Chawla</surname><given-names>S</given-names></name>, <name><surname>Gupta</surname><given-names>M</given-names></name>, <name><surname>Gupta</surname><given-names>R</given-names></name>, <name><surname>Goyal</surname><given-names>S</given-names></name>, <name><surname>Sharma</surname><given-names>P</given-names></name>, <name><surname>Mathew</surname><given-names>MA</given-names></name>, <name><surname>Jacob</surname><given-names>TJK</given-names></name>, <name><surname>Sundaram</surname><given-names>B</given-names></name>, <name><surname>Purushothaman</surname><given-names>GKC</given-names></name>, <name><surname>Dorairaj</surname><given-names>P</given-names></name>, <name><surname>Jagannatham</surname><given-names>M</given-names></name>, <name><surname>Murugiah</surname><given-names>K</given-names></name>, <name><surname>Boopathy</surname><given-names>H</given-names></name>, <name><surname>Maniam</surname><given-names>R</given-names></name>, <name><surname>Gurusamy</surname><given-names>R</given-names></name>, <name><surname>Kumaravel</surname><given-names>S</given-names></name>, <name><surname>Shenoy</surname><given-names>A</given-names></name>, <name><surname>Jain</surname><given-names>H</given-names></name>, <name><surname>Goswami</surname><given-names>JK</given-names></name>, <name><surname>Wakhlu</surname><given-names>A</given-names></name>, <name><surname>Gupta</surname><given-names>V</given-names></name>, <name><surname>Vinayagamurthy</surname><given-names>G</given-names></name>, <name><surname>Parashar</surname><given-names>UD</given-names></name>, <name><surname>Kang</surname><given-names>G</given-names></name>, <article-title>Intussusception after Rotavirus Vaccine Introduction in India</article-title>, <source>New Engl. J. Med</source>
<volume>383</volume> (<issue>20</issue>) (<year>2020</year>) <fpage>1932</fpage>&#x02013;<lpage>1940</lpage>.<pub-id pub-id-type="pmid">33176083</pub-id>
</mixed-citation></ref><ref id="R18"><label>[18]</label><mixed-citation publication-type="journal"><name><surname>Desselberger</surname><given-names>U</given-names></name>, <article-title>Differences of Rotavirus Vaccine Effectiveness by Country: Likely Causes and Contributing Factors</article-title>, <source>Pathogens</source>
<volume>6</volume> (<issue>4</issue>) (<year>2017</year>).</mixed-citation></ref><ref id="R19"><label>[19]</label><mixed-citation publication-type="journal"><name><surname>Groome</surname><given-names>MJ</given-names></name>, <name><surname>Tate</surname><given-names>JE</given-names></name>, <name><surname>Arnold</surname><given-names>M</given-names></name>, <name><surname>Chitnis</surname><given-names>M</given-names></name>, <name><surname>Cox</surname><given-names>S</given-names></name>, <name><surname>de Vos</surname><given-names>C</given-names></name>, <name><surname>Kirsten</surname><given-names>M</given-names></name>, <name><surname>le Grange</surname><given-names>SM</given-names></name>, <name><surname>Loveland</surname><given-names>J</given-names></name>, <name><surname>Machaea</surname><given-names>S</given-names></name>, <name><surname>Maharaj</surname><given-names>A</given-names></name>, <name><surname>Andrews</surname><given-names>N</given-names></name>, <name><surname>Madhi</surname><given-names>SA</given-names></name>, <name><surname>Parashar</surname><given-names>UD</given-names></name>, <article-title>Evaluation of Intussusception After Oral Monovalent Rotavirus Vaccination in South Africa</article-title>, <source>Clin. Infect. Dis</source>
<volume>70</volume> (<issue>8</issue>) (<year>2020</year>) <fpage>1606</fpage>&#x02013;<lpage>1612</lpage>.<pub-id pub-id-type="pmid">31125061</pub-id>
</mixed-citation></ref><ref id="R20"><label>[20]</label><mixed-citation publication-type="journal"><name><surname>Bines</surname><given-names>JE</given-names></name>, <name><surname>Kohl</surname><given-names>KS</given-names></name>, <name><surname>Forster</surname><given-names>J</given-names></name>, <name><surname>Zanardi</surname><given-names>LR</given-names></name>, <name><surname>Davis</surname><given-names>RL</given-names></name>, <name><surname>Hansen</surname><given-names>J</given-names></name>, <name><surname>Murphy</surname><given-names>TM</given-names></name>, <name><surname>Music</surname><given-names>S</given-names></name>, <name><surname>Niu</surname><given-names>M</given-names></name>, <name><surname>Varricchio</surname><given-names>F</given-names></name>, <name><surname>Vermeer</surname><given-names>P</given-names></name>, <name><surname>Wong</surname><given-names>EJ</given-names></name>, <name><surname>Brighton</surname><given-names>G</given-names></name>
<article-title>Collaboration Intussusception Working, Acute intussusception in infants and children as an adverse event following immunization: case definition and guidelines of data collection, analysis, and presentation</article-title>, <source>Vaccine</source>
<volume>22</volume>(<issue>5&#x02013;6</issue>) (<year>2004</year>) <fpage>569</fpage>&#x02013;<lpage>574</lpage>.<pub-id pub-id-type="pmid">14741146</pub-id>
</mixed-citation></ref><ref id="R21"><label>[21]</label><mixed-citation publication-type="journal"><name><surname>Willetts</surname><given-names>IE</given-names></name>, <name><surname>Kite</surname><given-names>P</given-names></name>, <name><surname>Barclay</surname><given-names>GR</given-names></name>, <name><surname>Banks</surname><given-names>RE</given-names></name>, <name><surname>Rumley</surname><given-names>A</given-names></name>, <name><surname>Allgar</surname><given-names>V</given-names></name>, <name><surname>Stringer</surname><given-names>MD</given-names></name>, <article-title>Endotoxin, cytokines and lipid peroxides in children with intussusception</article-title>, <source>Br. J. Surg</source>
<volume>88</volume> (<issue>6</issue>) (<year>2001</year>) <fpage>878</fpage>&#x02013;<lpage>883</lpage>.<pub-id pub-id-type="pmid">11412262</pub-id>
</mixed-citation></ref><ref id="R22"><label>[22]</label><mixed-citation publication-type="journal"><name><surname>Warfield</surname><given-names>KL</given-names></name>, <name><surname>Blutt</surname><given-names>SE</given-names></name>, <name><surname>Crawford</surname><given-names>SE</given-names></name>, <name><surname>Kang</surname><given-names>G</given-names></name>, <name><surname>Conner</surname><given-names>ME</given-names></name>, <article-title>Rotavirus infection enhances lipopolysaccharide-induced intussusception in a mouse model</article-title>, <source>J. Virol</source>
<volume>80</volume> (<issue>24</issue>) (<year>2006</year>) <fpage>12377</fpage>&#x02013;<lpage>12386</lpage>.<pub-id pub-id-type="pmid">17005639</pub-id>
</mixed-citation></ref><ref id="R23"><label>[23]</label><mixed-citation publication-type="journal"><name><surname>Smiley</surname><given-names>KL</given-names></name>, <name><surname>McNeal</surname><given-names>MM</given-names></name>, <name><surname>Basu</surname><given-names>M</given-names></name>, <name><surname>Choi</surname><given-names>AH</given-names></name>, <name><surname>Clements</surname><given-names>JD</given-names></name>, <name><surname>Ward</surname><given-names>RL</given-names></name>, <article-title>Association of gamma interferon and interleukin-17 production in intestinal CD4+ T cells with protection against rotavirus shedding in mice intranasally immunized with VP6 and the adjuvant LT(R192G)</article-title>, <source>J. Virol</source>
<volume>81</volume> (<issue>8</issue>) (<year>2007</year>) <fpage>3740</fpage>&#x02013;<lpage>3748</lpage>.<pub-id pub-id-type="pmid">17251301</pub-id>
</mixed-citation></ref><ref id="R24"><label>[24]</label><mixed-citation publication-type="journal"><name><surname>Bhavsar</surname><given-names>I</given-names></name>, <name><surname>Miller</surname><given-names>CS</given-names></name>, <name><surname>Al-Sabbagh</surname><given-names>M</given-names></name>, <article-title>Macrophage Inflammatory Protein-1 Alpha (MIP-1 alpha)/CCL3: As a Biomarker</article-title>, <source>General Methods in Biomarker Research and their Applications</source> (<year>2015</year>) <fpage>223</fpage>&#x02013;<lpage>249</lpage>.</mixed-citation></ref><ref id="R25"><label>[25]</label><mixed-citation publication-type="journal"><name><surname>Ren</surname><given-names>K</given-names></name>, <name><surname>Torres</surname><given-names>R</given-names></name>, <article-title>Role of interleukin-1beta during pain and inflammation</article-title>, <source>Brain Res. Rev</source>
<volume>60</volume> (<issue>1</issue>) (<year>2009</year>) <fpage>57</fpage>&#x02013;<lpage>64</lpage>.<pub-id pub-id-type="pmid">19166877</pub-id>
</mixed-citation></ref><ref id="R26"><label>[26]</label><mixed-citation publication-type="journal"><name><surname>Liao</surname><given-names>W</given-names></name>, <name><surname>Lin</surname><given-names>JX</given-names></name>, <name><surname>Leonard</surname><given-names>WJ</given-names></name>, <article-title>IL-2 family cytokines: new insights into the complex roles of IL-2 as a broad regulator of T helper cell differentiation</article-title>, <source>Curr. Opin. Immunol</source>
<volume>23</volume> (<issue>5</issue>) (<year>2011</year>) <fpage>598</fpage>&#x02013;<lpage>604</lpage>.<pub-id pub-id-type="pmid">21889323</pub-id>
</mixed-citation></ref><ref id="R27"><label>[27]</label><mixed-citation publication-type="journal"><name><surname>Bikker</surname><given-names>A</given-names></name>, <name><surname>Hack</surname><given-names>CE</given-names></name>, <name><surname>Lafeber</surname><given-names>FP</given-names></name>, <name><surname>van Roon</surname><given-names>JA</given-names></name>, <article-title>Interleukin-7: a key mediator in T cell-driven autoimmunity, inflammation, and tissue destruction</article-title>, <source>Curr. Pharm Des</source>
<volume>18</volume> (<issue>16</issue>) (<year>2012</year>) <fpage>2347</fpage>&#x02013;<lpage>2356</lpage>.<pub-id pub-id-type="pmid">22390698</pub-id>
</mixed-citation></ref><ref id="R28"><label>[28]</label><mixed-citation publication-type="journal"><name><surname>Kshirsagar</surname><given-names>AY</given-names></name>, <name><surname>Jagtap</surname><given-names>SV</given-names></name>, <name><surname>Kanojiya</surname><given-names>RP</given-names></name>, <name><surname>Langade</surname><given-names>YB</given-names></name>, <name><surname>Shinde</surname><given-names>SL</given-names></name>, <name><surname>Shekhar</surname><given-names>N</given-names></name>, <article-title>Eosinophilic enteritis presenting as a rare cause for ileo-ileal intussusception</article-title>, <source>World J. Gastroenterol</source>
<volume>13</volume> (<issue>47</issue>) (<year>2007</year>) <fpage>6444</fpage>&#x02013;<lpage>6445</lpage>.<pub-id pub-id-type="pmid">18081239</pub-id>
</mixed-citation></ref><ref id="R29"><label>[29]</label><mixed-citation publication-type="journal"><name><surname>Shin</surname><given-names>WG</given-names></name>, <name><surname>Park</surname><given-names>CH</given-names></name>, <name><surname>Lee</surname><given-names>YS</given-names></name>, <name><surname>Kim</surname><given-names>KO</given-names></name>, <name><surname>Yoo</surname><given-names>KS</given-names></name>, <name><surname>Kim</surname><given-names>JH</given-names></name>, <name><surname>Park</surname><given-names>CK</given-names></name>, <article-title>Eosinophilic enteritis presenting as intussusception in adult</article-title>, <source>Korean J. Intern. Med</source>
<volume>22</volume> (<issue>1</issue>) (<year>2007</year>) <fpage>13</fpage>&#x02013;<lpage>17</lpage>.<pub-id pub-id-type="pmid">17427639</pub-id>
</mixed-citation></ref><ref id="R30"><label>[30]</label><mixed-citation publication-type="journal"><name><surname>Bramuzzo</surname><given-names>M</given-names></name>, <name><surname>Martelossi</surname><given-names>S</given-names></name>, <name><surname>Villanacci</surname><given-names>V</given-names></name>, <name><surname>Maschio</surname><given-names>M</given-names></name>, <name><surname>Costa</surname><given-names>S</given-names></name>, <name><surname>Ventura</surname><given-names>A</given-names></name>, <article-title>Ileoileal Intussusceptions Caused by Eosinophilic Enteropathy</article-title>, <source>J. Pediatr. Gastroenterol. Nutr</source>
<volume>62</volume> (<issue>6</issue>) (<year>2016</year>), <fpage>e60</fpage>.<pub-id pub-id-type="pmid">25000350</pub-id>
</mixed-citation></ref><ref id="R31"><label>[31]</label><mixed-citation publication-type="journal"><name><surname>Gandhi</surname><given-names>GR</given-names></name>, <name><surname>Santos</surname><given-names>VS</given-names></name>, <name><surname>Denadai</surname><given-names>M</given-names></name>, <name><surname>da Silva Calisto</surname><given-names>VK</given-names></name>, <name><surname>de Souza Siqueira</surname><given-names>J</given-names></name>, <name><surname>de Quintans</surname><given-names>ESAM</given-names></name>, <name><surname>de Oliveira</surname><given-names>AA</given-names></name>, <name><surname>Souza Araujo</surname><given-names>N</given-names></name>, <name><surname>Narain</surname><given-names>LE</given-names></name>, <name><surname>Cuevas</surname><given-names>LJQ</given-names></name>, <name><surname>Gurgel Junior</surname><given-names>RQ</given-names></name>, <article-title>Cytokines in the management of rotavirus infection: A systematic review of in vivo studies</article-title>, <source>Cytokine</source>
<volume>96</volume> (<year>2017</year>) <fpage>152</fpage>&#x02013;<lpage>160</lpage>.<pub-id pub-id-type="pmid">28414969</pub-id>
</mixed-citation></ref><ref id="R32"><label>[32]</label><mixed-citation publication-type="journal"><name><surname>Desselberger</surname><given-names>U</given-names></name>, <name><surname>Huppertz</surname><given-names>HI</given-names></name>, <article-title>Immune responses to rotavirus infection and vaccination and associated correlates of protection</article-title>, <source>J. Infectious Dis</source>
<volume>203</volume> (<issue>2</issue>) (<year>2011</year>) <fpage>188</fpage>&#x02013;<lpage>195</lpage>.<pub-id pub-id-type="pmid">21288818</pub-id>
</mixed-citation></ref><ref id="R33"><label>[33]</label><mixed-citation publication-type="journal"><name><surname>Arican</surname><given-names>O</given-names></name>, <name><surname>Aral</surname><given-names>M</given-names></name>, <name><surname>Sasmaz</surname><given-names>S</given-names></name>, <name><surname>Ciragil</surname><given-names>P</given-names></name>, <article-title>Serum levels of TNF-alpha, IFN-gamma, IL-6, IL-8, IL-12, IL-17, and IL-18 in patients with active psoriasis and correlation with disease severity</article-title>, <source>Mediators Inflamm</source>. <volume>2005</volume> (<issue>5</issue>) (<year>2005</year>) <fpage>273</fpage>&#x02013;<lpage>279</lpage>.<pub-id pub-id-type="pmid">16258194</pub-id>
</mixed-citation></ref><ref id="R34"><label>[34]</label><mixed-citation publication-type="journal"><name><surname>Abadie</surname><given-names>V</given-names></name>, <name><surname>Jabri</surname><given-names>B</given-names></name>, <article-title>IL-15: a central regulator of celiac disease immunopathology</article-title>, <source>Immunol. Rev</source>
<volume>260</volume> (<issue>1</issue>) (<year>2014</year>) <fpage>221</fpage>&#x02013;<lpage>234</lpage>.<pub-id pub-id-type="pmid">24942692</pub-id>
</mixed-citation></ref><ref id="R35"><label>[35]</label><mixed-citation publication-type="journal"><name><surname>Fehniger</surname><given-names>TA</given-names></name>, <name><surname>Caligiuri</surname><given-names>MA</given-names></name>, <article-title>Interleukin 15: biology and relevance to human disease</article-title>, <source>Blood</source>
<volume>97</volume> (<issue>1</issue>) (<year>2001</year>) <fpage>14</fpage>&#x02013;<lpage>32</lpage>.<pub-id pub-id-type="pmid">11133738</pub-id>
</mixed-citation></ref><ref id="R36"><label>[36]</label><mixed-citation publication-type="journal"><name><surname>Yadav</surname><given-names>A</given-names></name>, <name><surname>Saini</surname><given-names>V</given-names></name>, <name><surname>Arora</surname><given-names>S</given-names></name>, <article-title>MCP-1: chemoattractant with a role beyond immunity: a review</article-title>, <source>Clin. Chim. Acta</source>
<volume>411</volume> (<issue>21&#x02013;22</issue>) (<year>2010</year>) <fpage>1570</fpage>&#x02013;<lpage>1579</lpage>.<pub-id pub-id-type="pmid">20633546</pub-id>
</mixed-citation></ref><ref id="R37"><label>[37]</label><mixed-citation publication-type="journal"><name><surname>Hamilton</surname><given-names>JA</given-names></name>, <article-title>GM-CSF in inflammation and autoimmunity</article-title>, <source>Trends Immunol</source>. <volume>23</volume> (<issue>8</issue>) (<year>2002</year>) <fpage>403</fpage>&#x02013;<lpage>408</lpage>.<pub-id pub-id-type="pmid">12133803</pub-id>
</mixed-citation></ref><ref id="R38"><label>[38]</label><mixed-citation publication-type="journal"><name><surname>Boneberg</surname><given-names>EM</given-names></name>, <name><surname>Hartung</surname><given-names>T</given-names></name>, <article-title>Molecular aspects of anti-inflammatory action of G-CSF</article-title>, <source>Inflammat. Res. Off. J. Eur. Histamine Res. Soc</source>
<volume>51</volume> (<issue>3</issue>) (<year>2002</year>) <fpage>119</fpage>&#x02013;<lpage>128</lpage>.</mixed-citation></ref><ref id="R39"><label>[39]</label><mixed-citation publication-type="journal"><name><surname>Sasaki</surname><given-names>K</given-names></name>, <name><surname>Fujita</surname><given-names>I</given-names></name>, <name><surname>Hamasaki</surname><given-names>Y</given-names></name>, <name><surname>Miyazaki</surname><given-names>S</given-names></name>, <article-title>Differentiating between bacterial and viral infection by measuring both C-reactive protein and 2&#x02019;-5&#x02019;-oligoadenylate synthetase as inflammatory markers</article-title>, <source>J. Infect. Chemother</source>
<volume>8</volume> (<issue>1</issue>) (<year>2002</year>) <fpage>76</fpage>&#x02013;<lpage>80</lpage>.<pub-id pub-id-type="pmid">11957124</pub-id>
</mixed-citation></ref><ref id="R40"><label>[40]</label><mixed-citation publication-type="journal"><name><surname>Korppi</surname><given-names>M</given-names></name>, <name><surname>Kroger</surname><given-names>L</given-names></name>, <article-title>C-reactive protein in viral and bacterial respiratory infection in children, Scand</article-title>. <source>J. Infect. Dis</source>
<volume>25</volume> (<issue>2</issue>) (<year>1993</year>) <fpage>207</fpage>&#x02013;<lpage>213</lpage>.</mixed-citation></ref><ref id="R41"><label>[41]</label><mixed-citation publication-type="journal"><name><surname>Foster</surname><given-names>Stephan</given-names></name>, <article-title>Rotavirus Vaccine and Intussusception</article-title>, <source>J. Pediatric Pharmacol. Therapeut</source>
<volume>12</volume> (<issue>1</issue>) (<year>2007</year>) <fpage>4</fpage>&#x02013;<lpage>7</lpage>, <pub-id pub-id-type="doi">10.5863/1551-6776-12.1.4</pub-id>.</mixed-citation></ref></ref-list></back><floats-group><fig position="float" id="F1"><label>Fig. 1.</label><caption><p id="P36">Increased detection of CRP in the serum of children with acute Intussusception. Serum was collected from children admitted for acute intussusception (IS Case), routine surgical procedures (surgical Control) or acute gastroenteritis symptoms (AGE Control). IS Case n = 407; Surgical Control n = 235; AGE Control n = 68. Statistical analysis was performed to compare mean CRP levels with SEM by using one-way ANOVA with Tukey&#x02019;s multiple comparison test. ns: not significant p &#x02265; 0.05; **** p &#x0003c; 0.0001. CRP: C-reactive protein; IS: Intussusception; AGE: Acute Gastroenteritis.</p></caption><graphic xlink:href="nihms-2011667-f0001" position="float"/></fig><table-wrap position="float" id="T1"><label>Table 1</label><caption><p id="P37">Characteristics of the study participants enrolled from September 2013 to January 2018.</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" valign="top" rowspan="1" colspan="1"/><th align="left" valign="top" rowspan="1" colspan="1">IS Case<break/>Patients</th><th align="left" valign="top" rowspan="1" colspan="1">Surgical Control<break/>Patients</th><th align="left" valign="top" rowspan="1" colspan="1">AGE Control<break/>Patients</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">Total number</td><td align="left" valign="top" rowspan="1" colspan="1">407</td><td align="left" valign="top" rowspan="1" colspan="1">235</td><td align="left" valign="top" rowspan="1" colspan="1">68</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Gender</td><td align="left" valign="top" rowspan="1" colspan="1">N <italic toggle="yes">(%)</italic></td><td align="left" valign="top" rowspan="1" colspan="1">N <italic toggle="yes">(%)</italic></td><td align="left" valign="top" rowspan="1" colspan="1">N <italic toggle="yes">(%)</italic></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Female</td><td align="left" valign="top" rowspan="1" colspan="1">182 <italic toggle="yes">(44.7%)</italic></td><td align="left" valign="top" rowspan="1" colspan="1">59 <italic toggle="yes">(25.1%)</italic></td><td align="left" valign="top" rowspan="1" colspan="1">28 <italic toggle="yes">(41.2%)</italic></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Male</td><td align="left" valign="top" rowspan="1" colspan="1">224 <italic toggle="yes">(55.0%)</italic></td><td align="left" valign="top" rowspan="1" colspan="1">172 <italic toggle="yes">(73.2%)</italic>
<xref rid="TFN1" ref-type="table-fn">**</xref></td><td align="left" valign="top" rowspan="1" colspan="1">40 <italic toggle="yes">(58.8%)</italic></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Unknown</td><td align="left" valign="top" rowspan="1" colspan="1">1 <italic toggle="yes">(0.3%)</italic></td><td align="left" valign="top" rowspan="1" colspan="1">4 <italic toggle="yes">(1.7%)</italic></td><td align="left" valign="top" rowspan="1" colspan="1">0 <italic toggle="yes">(0%)</italic></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">RV vaccination status</td><td align="left" valign="top" rowspan="1" colspan="1">N <italic toggle="yes">(%)</italic></td><td align="left" valign="top" rowspan="1" colspan="1">N <italic toggle="yes">(%)</italic></td><td align="left" valign="top" rowspan="1" colspan="1">N <italic toggle="yes">(%)</italic></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;RV vaccinated (at least one dose)</td><td align="left" valign="top" rowspan="1" colspan="1">358 <italic toggle="yes">(88.0%)</italic></td><td align="left" valign="top" rowspan="1" colspan="1">212 <italic toggle="yes">(90.2%)</italic></td><td align="left" valign="top" rowspan="1" colspan="1">64 <italic toggle="yes">(94.1%)</italic></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Non-RV vaccinated</td><td align="left" valign="top" rowspan="1" colspan="1">44 <italic toggle="yes">(10.8%)</italic></td><td align="left" valign="top" rowspan="1" colspan="1">17 <italic toggle="yes">(7.2%)</italic></td><td align="left" valign="top" rowspan="1" colspan="1">3 <italic toggle="yes">(4.4%)</italic></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Unknown</td><td align="left" valign="top" rowspan="1" colspan="1">5 <italic toggle="yes">(1.2%)</italic></td><td align="left" valign="top" rowspan="1" colspan="1">6 <italic toggle="yes">(2.6%)</italic></td><td align="left" valign="top" rowspan="1" colspan="1">1 <italic toggle="yes">(1.5%)</italic></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Age</td><td align="left" valign="top" rowspan="1" colspan="1">N <italic toggle="yes">(%)</italic></td><td align="left" valign="top" rowspan="1" colspan="1">N <italic toggle="yes">(%)</italic></td><td align="left" valign="top" rowspan="1" colspan="1">N <italic toggle="yes">(%)</italic></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;&#x0003c;1 month</td><td align="left" valign="top" rowspan="1" colspan="1">0 <italic toggle="yes">(0%)</italic></td><td align="left" valign="top" rowspan="1" colspan="1">1 <italic toggle="yes">(0.4%)</italic></td><td align="left" valign="top" rowspan="1" colspan="1">0 <italic toggle="yes">(0%)</italic></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;1&#x02013;6 months</td><td align="left" valign="top" rowspan="1" colspan="1">235 <italic toggle="yes">(57.7%)</italic></td><td align="left" valign="top" rowspan="1" colspan="1">117 <italic toggle="yes">(50.2%)</italic></td><td align="left" valign="top" rowspan="1" colspan="1">34 <italic toggle="yes">(50.0%)</italic></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;7&#x02013;12 months</td><td align="left" valign="top" rowspan="1" colspan="1">138 <italic toggle="yes">(33.9%)</italic></td><td align="left" valign="top" rowspan="1" colspan="1">91 <italic toggle="yes">(38.7%)</italic></td><td align="left" valign="top" rowspan="1" colspan="1">25 <italic toggle="yes">(36.8%)</italic></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;&#x0003e;12 months</td><td align="left" valign="top" rowspan="1" colspan="1">32 <italic toggle="yes">(7.9%)</italic></td><td align="left" valign="top" rowspan="1" colspan="1">22 <italic toggle="yes">(9.4%)</italic></td><td align="left" valign="top" rowspan="1" colspan="1">9 <italic toggle="yes">(13.2%)</italic></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Unknown</td><td align="left" valign="top" rowspan="1" colspan="1">2 <italic toggle="yes">(0.5%)</italic></td><td align="left" valign="top" rowspan="1" colspan="1">4 <italic toggle="yes">(1.7%)</italic></td><td align="left" valign="top" rowspan="1" colspan="1">0 <italic toggle="yes">(0%)</italic></td></tr></tbody></table><table-wrap-foot><fn id="TFN1"><p id="P38">IS: Intussusception; AGE: Acute Gastroenteritis; RV: Rotavirus. ** p &#x0003c; 0.01 with Chi-square test.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="T2"><label>Table 2</label><caption><p id="P39">Pro- and anti-inflammatory cytokines upregulated in the serum of IS case patients compared to surgical and AGE control patients.</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" valign="top" rowspan="1" colspan="1">Cytokines</th><th align="left" valign="top" rowspan="1" colspan="1">IS Case [pg/ml]</th><th align="left" valign="top" rowspan="1" colspan="1">Surgical Control<break/>[pg/ml]</th><th align="left" valign="top" rowspan="1" colspan="1">AGE Control<break/>[pg/ml]</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">Pro-inflammatory Cytokines</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">IFN-&#x003b3;</td><td align="left" valign="top" rowspan="1" colspan="1">41.2 (0.03&#x02013;518.1) <xref rid="TFN2" ref-type="table-fn">***</xref>/<xref rid="TFN2" ref-type="table-fn">*</xref></td><td align="left" valign="top" rowspan="1" colspan="1">18.2 (0.3&#x02013;334.5)</td><td align="left" valign="top" rowspan="1" colspan="1">21.9 (0.4&#x02013;214.4)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">TNF-&#x003b1;</td><td align="left" valign="top" rowspan="1" colspan="1">138.8 (3.0&#x02013;2,036) <xref rid="TFN2" ref-type="table-fn">*/ns</xref></td><td align="left" valign="top" rowspan="1" colspan="1">97.9 (3.0&#x02013;1,436)</td><td align="left" valign="top" rowspan="1" colspan="1">89.7 (17.4&#x02013;366.0)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">MIP-1&#x003b2;</td><td align="left" valign="top" rowspan="1" colspan="1">297.4 (0.4&#x02013;9,971) <xref rid="TFN2" ref-type="table-fn">*</xref>/ns</td><td align="left" valign="top" rowspan="1" colspan="1">180.5 (28.0&#x02013;1,974)</td><td align="left" valign="top" rowspan="1" colspan="1">165.3 (85.9&#x02013;531.2)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">IL-1&#x003b2;</td><td align="left" valign="top" rowspan="1" colspan="1">79.5 (0.06&#x02013;5,634) <xref rid="TFN2" ref-type="table-fn">*</xref>/ns</td><td align="left" valign="top" rowspan="1" colspan="1">3.9 (0.06&#x02013;135.2)</td><td align="left" valign="top" rowspan="1" colspan="1">2.6 (0.3&#x02013;27.4)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">IL-2</td><td align="left" valign="top" rowspan="1" colspan="1">23.2 (0.07&#x02013;426.6) <xref rid="TFN2" ref-type="table-fn">*</xref>/<xref rid="TFN2" ref-type="table-fn">*</xref></td><td align="left" valign="top" rowspan="1" colspan="1">14.9 (0.2&#x02013;288.1)</td><td align="left" valign="top" rowspan="1" colspan="1">9.4 (1.0&#x02013;60.8)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">IL-6</td><td align="left" valign="top" rowspan="1" colspan="1">348.5 (0.48&#x02013;15,326) <xref rid="TFN2" ref-type="table-fn">**</xref>/ns</td><td align="left" valign="top" rowspan="1" colspan="1">61.3 (0.2&#x02013;4,909)</td><td align="left" valign="top" rowspan="1" colspan="1">11.0 (1.6&#x02013;117.4)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">IL-7</td><td align="left" valign="top" rowspan="1" colspan="1">39.5 (0.63&#x02013;161.6) <xref rid="TFN2" ref-type="table-fn">***</xref>/ns</td><td align="left" valign="top" rowspan="1" colspan="1">28.6 (1.6&#x02013;106.4)</td><td align="left" valign="top" rowspan="1" colspan="1">34.1 (7.4&#x02013;73.2)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">IL-8</td><td align="left" valign="top" rowspan="1" colspan="1">2,538 (1.13&#x02013;113,307) <xref rid="TFN2" ref-type="table-fn">**</xref>/ns</td><td align="left" valign="top" rowspan="1" colspan="1">318.8 (1.3&#x02013;18,615)</td><td align="left" valign="top" rowspan="1" colspan="1">79.7 (12.6&#x02013;1,243)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">IL-17</td><td align="left" valign="top" rowspan="1" colspan="1">63.7 (1.64&#x02013;724.5) <xref rid="TFN2" ref-type="table-fn">*</xref>/ns</td><td align="left" valign="top" rowspan="1" colspan="1">50.2 (1.64&#x02013;738.0)</td><td align="left" valign="top" rowspan="1" colspan="1">35.4 (7.3&#x02013;175.1)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">PDGF-BB</td><td align="left" valign="top" rowspan="1" colspan="1">10,755 (333&#x02013;35,761) <xref rid="TFN2" ref-type="table-fn">***</xref>/<xref rid="TFN2" ref-type="table-fn">***</xref></td><td align="left" valign="top" rowspan="1" colspan="1">7,763 (781&#x02013;22,374)</td><td align="left" valign="top" rowspan="1" colspan="1">7,894 (50.4&#x02013;17,986)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Anti-inflammatory Cytokines</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">IL-1RA</td><td align="left" valign="top" rowspan="1" colspan="1">5,337 (150.5&#x02013;71,576) <xref rid="TFN2" ref-type="table-fn">***</xref>/<xref rid="TFN2" ref-type="table-fn">**</xref></td><td align="left" valign="top" rowspan="1" colspan="1">1,193 (46.1&#x02013;19,085)</td><td align="left" valign="top" rowspan="1" colspan="1">2,386 (161.3&#x02013;15,024)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">IL-4</td><td align="left" valign="top" rowspan="1" colspan="1">9.3 (0.06&#x02013;64.8) <xref rid="TFN2" ref-type="table-fn">***</xref>/ns</td><td align="left" valign="top" rowspan="1" colspan="1">6.5 (0.01&#x02013;54.5)</td><td align="left" valign="top" rowspan="1" colspan="1">6.9 (1.8&#x02013;16.7)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">IL-5</td><td align="left" valign="top" rowspan="1" colspan="1">58.0 (0.5&#x02013;564.4) <xref rid="TFN2" ref-type="table-fn">***</xref>/ns</td><td align="left" valign="top" rowspan="1" colspan="1">37.5 (1.1&#x02013;502.4)</td><td align="left" valign="top" rowspan="1" colspan="1">38.6 (3.4&#x02013;126.6)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">IL-13</td><td align="left" valign="top" rowspan="1" colspan="1">3.5 (0.1&#x02013;33.6) <xref rid="TFN2" ref-type="table-fn">*</xref>/ns</td><td align="left" valign="top" rowspan="1" colspan="1">2.8 (0.02&#x02013;23.1)</td><td align="left" valign="top" rowspan="1" colspan="1">3.1 (0.8&#x02013;8.6)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Basic FGF</td><td align="left" valign="top" rowspan="1" colspan="1">55.1 (1.7&#x02013;433.3) <xref rid="TFN2" ref-type="table-fn">**</xref>/ns</td><td align="left" valign="top" rowspan="1" colspan="1">43.5 (3.9&#x02013;339.5)</td><td align="left" valign="top" rowspan="1" colspan="1">41.07 (17.1&#x02013;119.4)</td></tr></tbody></table><table-wrap-foot><fn id="TFN2"><p id="P40">Values are mean (min-max). IL: Interleukin; IFN: Interferon; TNF: Tumor-Necrosis-Factor; MIP: Macrophage inflammatory protein; PDGF: platelet-derived growth factor; FGF: fibroblast growth factor; IS: Intussusception; AGE: Acute Gastroenteritis. * p &#x0003c; 0.05; ** p &#x0003c; 0.01; *** p &#x0003c; 0.001; ns not significant p &#x02265; 0.05, comparing IS case patients to surgical (first Asterix indicator) and AGE control (second Asterix indicator) patients using one-way ANOVA with Tukey&#x02019;s multiple comparison test. Difference between surgical control group and AGE control group were not statistically significant.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="T3"><label>Table 3</label><caption><p id="P41">Pro- and anti-inflammatory cytokines upregulated in the serum of IS case and surgical control patients compared to and AGE control patients.</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" valign="top" rowspan="1" colspan="1">Cytokines</th><th align="left" valign="top" rowspan="1" colspan="1">IS Case [pg/ml]</th><th align="left" valign="top" rowspan="1" colspan="1">Surgical Control<break/>[pg/ml]</th><th align="left" valign="top" rowspan="1" colspan="1">AGE Control [pg/<break/>ml]</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">Pro-inflammatory Cytokines</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">IL-12p70</td><td align="left" valign="top" rowspan="1" colspan="1">7.0 (0.2&#x02013;52.0) <xref rid="TFN3" ref-type="table-fn">*</xref></td><td align="left" valign="top" rowspan="1" colspan="1">6.5 (0.1&#x02013;85.4) ns</td><td align="left" valign="top" rowspan="1" colspan="1">4.3 (0.7&#x02013;15.9)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">IL-15</td><td align="left" valign="top" rowspan="1" colspan="1">155.9 (1.2&#x02013;1,270) <xref rid="TFN3" ref-type="table-fn">**</xref></td><td align="left" valign="top" rowspan="1" colspan="1">137.9 (1.2&#x02013;1,790) <xref rid="TFN3" ref-type="table-fn">*</xref></td><td align="left" valign="top" rowspan="1" colspan="1">65.4 (7.2&#x02013;343.7)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">GM-CSF</td><td align="left" valign="top" rowspan="1" colspan="1">5.3 (0.04&#x02013;89.4) <xref rid="TFN3" ref-type="table-fn">**</xref></td><td align="left" valign="top" rowspan="1" colspan="1">4.2 (0.2&#x02013;54.4) ns</td><td align="left" valign="top" rowspan="1" colspan="1">2.3 (0.03&#x02013;11.8)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">MCP-1</td><td align="left" valign="top" rowspan="1" colspan="1">252 (0.4&#x02013;7,191) ns</td><td align="left" valign="top" rowspan="1" colspan="1">197.0 (0.5&#x02013;9,913) ns</td><td align="left" valign="top" rowspan="1" colspan="1">64.1 (7.2&#x02013;869.4)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">MIP-1&#x003b1;</td><td align="left" valign="top" rowspan="1" colspan="1">203.0 (0.2&#x02013;6,039) ns</td><td align="left" valign="top" rowspan="1" colspan="1">166.6 (0.3&#x02013;4,483) ns</td><td align="left" valign="top" rowspan="1" colspan="1">16.5 (0.6&#x02013;252.5)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Anti-inflammatory Cytokine</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">G-CSF</td><td align="left" valign="top" rowspan="1" colspan="1">2,428 (6.6&#x02013;42,904) ns</td><td align="left" valign="top" rowspan="1" colspan="1">1,978 (17.4&#x02013;24,705) ns</td><td align="left" valign="top" rowspan="1" colspan="1">1,092 (260.2&#x02013;12,644)</td></tr></tbody></table><table-wrap-foot><fn id="TFN3"><p id="P42">Values are mean (min &#x02013; max). IL: Interleukin; GM-CSF: Granulocyte-macrophage colony-stimulating factor; MCP: Monocyte chemoattractant protein; MIP: Macrophage inflammatory protein; G-CSF: Granulocyte colony-stimulating factor; IS: Intussusception; AGE: Acute Gastroenteritis. * p &#x0003c; 0.05; ** p &#x0003c; 0.01; ns: not significant p &#x02265; 0.05, comparing IS case patients or surgical control patients to AGE control patients using one-way ANOVA with Tukey&#x02019;s multiple comparison test. Difference between IS case patients and surgical control patients are not significant for all cytokines shown here.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="T4"><label>Table 4</label><caption><p id="P43">Pro- and anti-inflammatory cytokines upregulated in the serum of IS case or AGE control patients compared to surgical control patients.</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" valign="top" rowspan="1" colspan="1">Cytokines</th><th align="left" valign="top" rowspan="1" colspan="1">IS Case</th><th align="left" valign="top" rowspan="1" colspan="1">Surgical Control</th><th align="left" valign="top" rowspan="1" colspan="1">AGE Control</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">Pro-inflammatory Cytokine</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Eotaxin</td><td align="left" valign="top" rowspan="1" colspan="1">109.7 (0.1&#x02013;650.0) <xref rid="TFN4" ref-type="table-fn">***</xref></td><td align="left" valign="top" rowspan="1" colspan="1">67.9 (5.9&#x02013;381.2)</td><td align="left" valign="top" rowspan="1" colspan="1">116.9 (27.5&#x02013;338.8) <xref rid="TFN4" ref-type="table-fn">***</xref></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Anti-inflammatory Cytokine</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">IL-10</td><td align="left" valign="top" rowspan="1" colspan="1">35.5 (0.4&#x02013;755.0) <xref rid="TFN4" ref-type="table-fn">***</xref></td><td align="left" valign="top" rowspan="1" colspan="1">13.9 (0.9&#x02013;140.8)</td><td align="left" valign="top" rowspan="1" colspan="1">25.2 (1.7&#x02013;145.7) ns</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Pro-inflammatory Cytokine</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">IP-10</td><td align="left" valign="top" rowspan="1" colspan="1">1,759 (3.1&#x02013;18,874) ns</td><td align="left" valign="top" rowspan="1" colspan="1">1,769 (66.9&#x02013;16,574)</td><td align="left" valign="top" rowspan="1" colspan="1">3,027 (490.7&#x02013;11,669) <xref rid="TFN4" ref-type="table-fn">***</xref></td></tr></tbody></table><table-wrap-foot><fn id="TFN4"><p id="P44">Values are mean (min &#x02013; max). IL: Interleukin; IP: Interferon-&#x003b3; induced protein; IS: Intussusception; AGE: Acute Gastroenteritis. *** p &#x0003c; 0.001; ns: not significant p &#x02265; 0.05, comparing IS case or AGE control patients to surgical control patients using one-way ANOVA with Tukey&#x02019;s multiple comparison test.</p></fn></table-wrap-foot></table-wrap></floats-group></article>